TRIDENT LIFELINE
Quarterly Results Analysis [Jun2023]
TRIDENT LIFELINE Quarterly Results
Consolidated | Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|
Revenues | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹6 Cr | ₹9 Cr |
Expenses | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹7 Cr |
Operating Income | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
Other Income | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
Profit After Tax | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr |
EPS | ₹1.22 | ₹1.72 | ₹1.75 | ₹0.88 | ₹3.46 |
Industry Peers & Returns | 1W | 1M | 1Y |
TRIDENT LIFELINE | -4.5% | 5.6% | 14.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.9% | 0.9% | 62.6% |
CIPLA | 3.5% | 4.2% | 51.8% |
DR REDDYS LABORATORIES | -1% | -2.4% | 28.4% |
ZYDUS LIFESCIENCES | 12.2% | 18% | 103.8% |
DIVIS LABORATORIES | 0.8% | 5.6% | 19.3% |
MANKIND PHARMA | -6.1% | -11.9% | 54.1% |
TORRENT PHARMACEUTICALS | 2.9% | 6.2% | 66.2% |
LUPIN | 1.5% | 4.2% | 109.2% |
TRIDENT LIFELINE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 2.19 % |
Y-o-Y | -3.47 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2023 | ₹9 Cr | 2.19 | |
Mar2023 | ₹8 Cr | -10.09 | |
Dec2022 | ₹9 Cr | 57.52 | |
Jun2022 | ₹6 Cr | -33.30 | |
Mar2022 | ₹9 Cr | - |
TRIDENT LIFELINE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -9.49 % |
Y-o-Y | 0.23 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2023 | ₹2 Cr | -9.49 | |
Mar2023 | ₹2 Cr | -1.37 | |
Dec2022 | ₹2 Cr | 128.55 | |
Jun2022 | ₹1 Cr | -50.88 | |
Mar2022 | ₹2 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -11.45 % |
Y-o-Y | 3.81 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2023 | 20.42% | -11.45 | |
Mar2023 | 23.06% | 9.71 | |
Dec2022 | 21.02% | 45.17 | |
Jun2022 | 14.48% | -26.39 | |
Mar2022 | 19.67% | - |
TRIDENT LIFELINE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -29.03 % |
Y-o-Y | -49.35 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2023 | ₹1 Cr | -29.03 | |
Mar2023 | ₹2 Cr | -1.84 | |
Dec2022 | ₹2 Cr | 187.30 | |
Jun2022 | ₹1 Cr | -74.69 | |
Mar2022 | ₹3 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -30.55 % |
Y-o-Y | -47.54 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2023 | 16.23 % | -30.55 | |
Mar2023 | 23.37 % | 9.15 | |
Dec2022 | 21.41 % | 82.37 | |
Jun2022 | 11.74 % | -62.06 | |
Mar2022 | 30.94 % | - |
TRIDENT LIFELINE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -29.07 % |
Y-o-Y | -64.74 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2023 | ₹1.22 | -29.07 | |
Mar2023 | ₹1.72 | -1.71 | |
Dec2022 | ₹1.75 | 98.86 | |
Jun2022 | ₹0.88 | -74.57 | |
Mar2022 | ₹3.46 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD